Dawn Health raises €21.5M Series B round
11 February 2026· Copenhagen, Denmark· health, digital_therapeutics, ai, b2b, pure_software
The growth investment will be used to expand the company's AI-enabled patient companion platform and further its role in the clinical trial space by digitizing the clinical-to-commercial pharmaceutical value chain.
Investors
LeadCipio Partners
Also participating
EIFOTrifork Group AGChr. Augustinus Fabrikker
About Dawn Health
Stage
Series B
Headquarters
Copenhagen, Denmark
Founded
2016
Team Size
51–200
Sectors
healthdigital_therapeuticsaib2bpure_software
Source: https://techfundingnews.com/dawn-health-bags-e21-5m-to-digitise-drug-trials-and-patient-engagement/